New study reveals smoking cessation drug not boosting number of smokers who quit
The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online Aug. 17 in Tobacco Control, suggest…